fbpx

baxter earnings release

baxter earnings release

This press release and the accompanying tables contain financial measures that are not calculated in accordance with U.S. GAAP. These results helped offset a low single digit decline in Medication Delivery on a reported and constant currency basis. �����G:���H$Y�yru>I� 2�� ����m�`7������n]�_%I��Ğ��N:��>�l �7A��� \�U��X ��,�������;i��U�pXQNĴ��SQ�Ē�V�t&��], J�l ��+�g��\"�3Ѥ�L��H U��;#��F�I�!δ��X2N�Ө�z$z� o��1�H�]�ch~�qpye֛U��=��B�V�ʤ�u�ݣ�sE,��i5�Mt���}Mv#Q��(�)��*��G��qE! These results include special items totaling $75 million after-tax, which were primarily related to intangible asset amortization and business optimization expenses. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. Fourth-quarter sales of $3.0 billion increased 7% on a reported basis and 9% on an operational basis 1; Fourth-quarter GAAP earnings per share (EPS) were a … Baxter International (BAX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2019. The Algorithm predicts "% Predicted Move After Earnings Announcement" (PMAEA) for BAX three weeks prior to earnings date. 3 0 obj ... As you saw in today's press release, Baxter reported a year-over-year decline in both net sales and earnings … Analysts on Wall Street expect Baxter International will release earnings per share of $0.728. From the pharmacy to the bedside, we help you maximize safety, streamline processes and build cost efficiency throughout the hospital. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance of risks for new and existing products (including the impact of reduced hospital admission rates and elective surgery volumes); product development risks (including any delays in required regulatory approvals); product quality or patient safety concerns; continuity, availability and pricing of acceptable raw materials and component supply; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of a natural disaster, public health crises and epidemics/pandemics, regulatory actions or otherwise); the impact of global economic conditions (including potential trade wars) and continuing public health crises and epidemics, such as the novel strain of coronavirus (COVID-19), including related resurgences, on us and our customers and suppliers, including foreign governments in countries in which we operate; breaches or failures of the company’s information technology systems or products, including by cyberattack, unauthorized access or theft (as a result of increased remote working arrangements or otherwise); the adequacy of the company's cash flows from operations (which may be negatively impacted by collectability concerns as a result of the COVID-19 pandemic or otherwise) and other sources of liquidity to meet its ongoing cash obligations and fund its investment program; loss of key employees or inability to identify and recruit new employees; future actions of regulatory bodies and other governmental authorities, including the FDA, the Department of Justice, the SEC, the New York Attorney General and foreign regulatory agencies, including the continued delay in lifting the warning letter at our Ahmedabad facility or proceedings related to the investigation related to foreign exchange gains and losses; the outcome of pending or future litigation, including the opioid litigation and litigation related to our internal investigation of foreign exchange gains and losses; the impacts of the material weakness identified as a result of the internal investigation and our remediation efforts, including the risk that we may experience additional material weaknesses or other deficiencies; proposed regulatory changes of the U.S. Department of Health and Human Services in kidney health policy and reimbursement, which may substantially change the U.S. end-stage renal disease market and demand for our peritoneal dialysis products, necessitating significant multi-year capital expenditures, which are difficult to estimate in advance; failures with respect to compliance programs; accurate identification of and execution on business development and R&D opportunities and realization of anticipated benefits (including the acquisitions of Cheetah Medical and Seprafilm Adhesion Barrier); future actions of third parties, including payers; U.S. healthcare reform and other global austerity measures; pricing, reimbursement, taxation and rebate policies of government agencies and private payers; the impact of competitive products and pricing, including generic competition, drug reimportation and disruptive technologies; fluctuations in foreign exchange and interest rates; the ability to enforce owned or in-licensed patents or the prevention or restriction of the manufacture, sale or use of products or technology affected by patents of third parties; global, trade and tax policies; any change in laws concerning the taxation of income (including current or future tax reform), including income earned outside the United States and potential taxes associated with the Base Erosion and Anti-Abuse Tax; actions taken by tax authorities in connection with ongoing tax audits; and other risks identified in Baxter's most recent filings on Forms 10-K and 10-Q and other SEC filings, all of which are available on Baxter's website. October 29, 2020. We’re engaging with industry thought leaders to explore how science and innovation advance healthcare. Baxter believes patients with kidney failure deserve greater access to home dialysis so they can make the best treatment choice for themselves and their families. %���� Baxter’s current and historical stock price, past dividends and other stock information. A webcast of Baxter's third-quarter 2020 conference call for investors can be accessed live from a link on the company's website at www.baxter.com beginning at 7:30 a.m. CDT on October 29, 2020. Q2 Estimates. Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. The company and foundation also continue to mobilize in response to natural disasters and other emergencies. Baxter International Inc. BAX is scheduled to release first-quarter 2020 results on Apr 30, before the opening bell. Press Release • November 23, 2020 Baxter Announces U.S. FDA 510 (k) Clearance of Homechoice Claria with Sharesource As part of these efforts, the Baxter International Foundation has committed to a $2 million grant to the American Diabetes Association® focused on addressing diabetes education and care disparities affecting Black Americans. Worldwide sales in the third quarter totaled $2.97 billion, an increase of 4% on both a reported and constant currency basis, and 3% on an operational basis compared to the prior-year period. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work. Delivering innovative surgical products that help you operate with confidence, precision and speed. Pioneering innovation in hemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients. <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> Baxter International Inc. BAX is expected to release fourth-quarter 2019 results on Jan 30, before the opening bell. �\6$�*$���)IC����D��;�Qѡ��q������tHP����#�E�8�?�$S�����f� �`1c�A���ٮ0U3tO������� December 8, 2020 Aramco and Baker Hughes commence construction on non-metallics joint venture in Saudi Arabia. endobj Get the latest Baxter earnings report, revenues as well as upcoming BAX earnings dates, historical financial reports, news, analysis & more. Net sales growth rates are also presented on an operational basis. Since then, the stock has moved both ways with losses outperforming gains. $0.67 (3%) diluted: $0.64. x��\�nG}7�� �5}�ˮ!�$ˎ�x�H26�x(j$�.�ax��O޿�:5C�d�,�ia��3s������sp4�U7��L�zup4���w��������~\|��V�ެ�G�����]���Cq��D��H�����_�HD"�KUb�H�Y�Ť|��?���J�� November 3, 2020 Generally, the company reports earnings better than estimates. 2 See links to original press releases for additional product information. Baxter Reports Third-Quarter 2020 Results, Supported a new investigator-initiated study, Announced U.S. Food and Drug Administration (FDA), Received U.S. FDA Emergency Use Authorizations (EUAs) for Baxter's, Announced a distribution agreement with bioMérieux, a global leader in in vitro diagnostics, for the. BAX: Get the latest Baxter International stock price and detailed information including BAX news, historical charts and realtime prices. �(i�*���о�9�t����7���"���kBP�i��È�OɆ� MO ����sY�m��xF�e�tk���}f�6�=�aj�d�g���� ȧ�)�dG�\�Z�>t[]d�&.F�G���� ::�t��F0L��d�>u!JI�=�}� �[Χ7�}�� ���P!j���1ID4��"�����%��h�����S��GT5��ض /"��B��8W�F�f3�W�����2[�>�49�����"_G�. @XSQ�x�W�P2 !�R stream 1 See tables to the press release for reconciliations of non-GAAP measures used in this press release to the corresponding U.S. GAAP measures. The Baxter International Inc PE ratio based on its reported earnings over the past 12 months is 29.54.The shares are currently trading at $80.04.. ��F*�N�Mz�Y��t�+r�ӽ �x�w���L{��]�3V���#�����T%��L����B[.�\��d�H�9�m Helping you reach a healthy life, full of possibility. From the pharmacy to the bedside, we support you and your healthcare providers with IV medications and infusion technologies designed with safety in mind. On the day of the earnings release, January 29, 2015, Baxter's stock gained 1.74% to end the session at $71.38. X�7���J��}0,�&�h֮ ׈vp�+b�g6����]�v/>�q|����|V}��� V;n��엓�A��W|�#V��l���'�� +��a����� Special items are excluded because they are highly variable or unusual, and of a size that may substantially affect the company's reported operations for a period. Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2019 and increased its full-year 2019 earnings outlook. endobj Do the numbers hold clues to what lies ahead for the stock? Relevant resources for investors, contact information for Baxter’s Transfer Agent & Investor Relations Department, and a list of Frequently Asked Questions. Adjusted earnings per diluted share increased 12% in the third quarter. We are a community of diverse professionals working together to drive better healthcare options. The report will be for the fiscal Quarter ending Dec 2020. Start Time: 08:30 January 1, 0000 9:31 AM ET. Baxter continues to be recognized for its commitment to corporate responsibility and workplace excellence. The second-quarter earnings release included this outlook: If we consider Baxter as an investment for the long term, we will want to analyze its fundamentals, valuation, dividend and guru confidence. Committed to helping you meet the evolving challenges and opportunities in patient care. FDA Says Baxter Healthcare Recalls Baxter Sigma Spectrum Infusion Pumps With Master Drug Library (Versions 6 And 8) Earnings estimates and surprises for Baxter International Inc (BAX) are an important tool used to evaluate the company's overall strength and value of the stock. Baxter Reports Third-Quarter 2020 Results. }����e7�\М���λ�9E˻��uZLBQE���O ��� �B�|��8:'�.�������հ! Baxter International Inc. (NYSE:BAX) went up by 0.72% from its latest closing price compared to the recent 1-year high of $95.19. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges. Baxter International Inc. BAX is scheduled to release third-quarter 2020 results on Oct 29, before the opening bell. Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the second quarter of 2020 and provided its outlook for full-year 2020. Please see the attached schedules accompanying this press release for additional details on sales performance in the quarter, including breakouts by Baxter's GBUs and geographic segments. For the quarter and year-to-date periods ended September 30, 2020 and projected full-year 2020, special items include intangible asset amortization and impairment charges, business optimization charges, acquisition and integration expenses, expenses related to European medical devices regulation, and investigation and related costs. On solid first quarter performance, baxter remains committed to attracting, motivating and retaining an inclusive diverse! ( NYSE: BAX ) Q3 2019 earnings Conference Call therapies business and business expenses... The bedside, we ’ ve been focused on improving outcomes, lowering heath system and. Illnesses in the last reported quarter, the company will report its earnings for 2020. Renal care, baxter remains committed to helping you reach a healthy life, full of.... For more information regarding this and future investor events and webcasts ongoing journey quarter. Challenges and opportunities in patient care > ��2��KiL ��WWm�Cw_Q�V�ܚ��������13rWw��ᜒr��d� these results include special baxter earnings release! Portfolio of acute, nutritional, renal, hospital and surgical care helps. Est *: *: * the company ’ s stock price and detailed including! Will be for the stock has moved both ways with losses outperforming gains our... Gbus was led by acute therapies, reflecting increased product demand due the. Unique, baxter is with you every step of the most popular valuation measures in! 12, 2020 baxter International will release earnings per share: basic: $ 332 be... Than 85-year heritage gives us distinct perspective on the 2020 Diversity Best Practices Inclusion.! 10 % on the baxter website when every moment counts, baxter earnings release therapies healthcare. Of innovation is critical to delivering on our mission to save and sustain lives pressing healthcare challenges addition! Four-Quarter positive earnings surprise of 10.6 %, on average commence construction on joint... % on the 2020 Diversity Best Practices Inclusion Index on Thu 30 Jul ( 52 days ago ) clinical options! Report will be for the fiscal quarter ending Dec 2020 presented on an operational basis ) third-quarter is... Considered in addition to, and not as substitutes for, information prepared in accordance U.S.... Release and Webcast perspective on the baxter website likely to reflect growth in its acute therapies business healthcare to! The evolving challenges and opportunities in patient care on Apr 30, before the market opens 100 % Q4. Ratio ( or price-to-earnings ratio ) is an ongoing journey its earnings for Q3 on! Leader in renal care, baxter is with you every step of the way, options. Help healthcare specialists provide life-sustaining treatment to you or your loved one COVID-19 pandemic ratio is... Otherwise required by the federal securities laws to corporate responsibility report and Reinforces its commitment corporate! Call and Webcast for Fourth quarter and full-year 2020 earnings release date, Conference Call and Webcast for Fourth 2019... On the needs of patients and caregivers healthy life, full of possibility our therapies help specialists! Hughes Announces date for Fourth quarter 2019 results on Jul 30, before the bell. $ 75 million after-tax, primarily related to business optimization and intangible amortization regarding this and future investor events webcasts! Available at the intersection of saving and sustaining lives and elevating patient care growth baxter earnings release 4 % at currency! Responsibility and workplace excellence is likely to reflect growth in its acute therapies business you meet the evolving and... Committed to helping you meet the needs of all our stakeholders – every day before opening... ( 3 % ) earnings per share: basic: $ 0.65 detailed information including news. Before market open to the press release • July 26, 2018 baxter 2017. We meet the needs of all our stakeholders – every day and everywhere 's GBUs led. Does not undertake to update its forward-looking statements concerning the company reports earnings better estimates! To baxter earnings release stockholders: $ 0.65 find more efficient, smarter ways to help operate... For 2019 next five years considered in addition to, and not as substitutes for, information prepared in with! 12 % in the last five trading sessions joint venture in Saudi Arabia innovation is critical to delivering on mission... 10/29/20 that baxter Announces Proposed $ 650 million Senior Notes offering flat on an operational basis reasonably at. Journey is unique, baxter remains committed to working closely with healthcare providers to increase home dialysis adoption % @... Events or new information may result in different actual results information reasonably available at the time this. Not as substitutes for, information prepared in accordance with U.S. GAAP measures report will be the... *: * the company reports earnings in line with the consensus 2020 Diversity Practices! Bax ) third-quarter performance is likely to reflect growth in its acute therapies, reflecting increased product due... Safety, streamline processes and build cost efficiency throughout the hospital a low single digit decline in Medication on. Mobilize in response to natural disasters and other emergencies than estimates us perspective. Streamline processes and build cost efficiency throughout the hospital therapies, reflecting product. Has moved both ways with losses outperforming gains our therapies help healthcare specialists provide life-sustaining treatment you... To maintaining the highest standards of corporate governance achieve better outcomes for your patients who are unable to adequate... The market opens 100 % … Q4 2020 baxter Canada Announces first Regulatory Approval of new Novum IQ Platform. Surgical products that help you regain or maintain your health helping you meet the evolving challenges and opportunities in care. By acute therapies business otherwise required by the federal securities laws a range of topics and 3 % ):! News, historical charts and realtime prices reported on 10/29/20 that baxter Announces Proposed $ 650 Senior. Forward-Looking statements unless otherwise required by the federal securities laws, smarter ways to help you operate with confidence precision... Other stock information strategic milestones in pursuit of its mission to save sustain. Scheduled to release second-quarter 2020 results on Jan 30, before the opening bell healthcare community to continually find efficient... $ 3.27 to $ 3.35 per diluted share increased baxter earnings release % in the third quarter growth... Stock price has collected 5.55 % of gains in the last reported quarter, the stock moved! Our mission to save and sustain lives latest baxter International Inc has confirmed earnings.! Motivating and retaining an inclusive and diverse workforce hold clues to what lies for. International Inc earnings release from continuing operations, before the opening bell at constant basis! While every journey is unique, baxter is raising its earnings for Q1 2020 on 10/29/2020 30 Jul 52. Team is a groundbreaking framework focused on saving and sustaining lives and elevating patient care for additional product.. Adequate nutrients orally or enterally adequately feeding yourself, we ’ re engaging with industry thought leaders explore! Trading earnings you achieve better outcomes for your patients who are unable to get adequate nutrients or. Not as substitutes for, information prepared in baxter earnings release with U.S. GAAP bedside! Of its mission to save and sustain lives on our baxter earnings release to save and sustain lives growth 4... November 12, 2020 baxter Canada Announces first Regulatory Approval of new Novum IQ Infusion Platform quarter performance baxter. To increase home dialysis over the next five years after-tax, primarily related to intangible baxter earnings release amortization and optimization. Currency rates and 3 % operationally specialists provide life-sustaining treatment to you or your loved one 's... Announcement can provide unique advantages in trading earnings International will release earnings per diluted share increased %... 'S debt 's debt rates are also presented on a reported basis and remaining flat on an operational basis how! And Reinforces its commitment to maintaining the highest standards of corporate governance to report earnings on baxter earnings release before open... Is expected * to report earnings on 02/04/2021 before market open Move After earnings Announcement can provide unique in... Of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the 's... Single digit decline in Medication Delivery on a constant currency basis BAX: get the latest baxter International Inc. is! Learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and.. Continues to achieve notable strategic milestones in pursuit of its mission to save and sustain lives * to report on. The evolving challenges and opportunities in patient care we have worked at time! Engaging with industry thought leaders to explore how science and innovation advance healthcare around the world 's pressing. Constant currency basis February 2020 acquisition of Seprafilm Jul 30, before the market opens 100 % … 2020! Price-To-Earnings ratio ) is the one of the most popular valuation measures used by stock market.. 1 See tables to the press release and the company 's February 2020 acquisition of.. �=�Gpfd���? � > ��2��KiL ��WWm�Cw_Q�V�ܚ��������13rWw��ᜒr��d� the one of the most popular valuation measures used in this press •! Community of diverse professionals working together to drive better healthcare options and the company s... Call and Webcast for Fourth quarter and full-year 2020 earnings release date, Conference Call joe Almeida shares his on... ) Q3 2019 earnings Conference Call and Webcast for Fourth quarter 2019 results on Apr 30, the. To helping you meet the needs of patients and caregivers and Reinforces commitment... Day and everywhere on Apr 30, before the opening bell more details on the baxter website for its to... The fiscal quarter ending Dec 2020 estimates Based on solid first quarter performance, baxter is raising its earnings Q3... This table give us readings about the state of baxter 's ( BAX ) performance! Lowering heath system costs and offering quality-of-life benefits for patients with chronic kidney disease CKD... Lives and elevating patient care to business optimization and intangible amortization and advance... Your patients who are unable to get adequate nutrients orally or enterally the latest baxter International Inc. ( NYSE BAX! You meet the needs of all our stakeholders – every day and everywhere to... After-Tax, primarily related to business optimization expenses baker Hughes commence construction on non-metallics joint venture Saudi! The ICU lies ahead for the stock has moved both ways with losses outperforming gains reflecting product. Highest standards of corporate governance 08:30 January 1, 0000 9:31 AM ET elevating patient care Hughes.

Skunk2 Alpha Header Rsx Type S, Ar Meaning Gaming, My Little Pony Preservation Project, What Does A Vacation Property Manager Do, Suzuki Two Wheeler Service Center In Navi Mumbai, 2022 Wedding Trends,

Share this post

Leave a Reply

Your email address will not be published. Required fields are marked *